Rivory
Laurent P. Rivory, New South Wales AU
Patent application number | Description | Published |
---|---|---|
20090028862 | Emmprin antagonists and uses thereof - EMMPRIN (Extracellular Matrix Metalloproteinase Inducer) antagonists, such as antibodies, including specified portions or variants, siRNA, shRNA, antisense and DNAzymes, can be used to treat pathological processes associated with proliferative diseases, such as cancer, by specifically preventing or inhibiting the ability of proliferating tissue to develop a blood supply. | 01-29-2009 |
Laurent Pierre Rivory, New South Wales AU
Patent application number | Description | Published |
---|---|---|
20090192103 | Multitargeting Interfering RNAs Having Two Active Strands And Methods For Their Design And Use - Interfering RNA molecules are now designed and produced with specificity for multiple binding sequences present in distinct genetic contexts in one or more pre-selected target RNA molecules and are used to modulate expression of the target sequences. The multitargeting interfering RNA molecules have two strands that target multiple target sites on one or more pre-selected RNA molecules. Such a multitargeting interfering RNA approach provides a powerful tool for gene regulation. | 07-30-2009 |
20090239816 | Multitargeting Interfering RNAs And Methods Of Their Use And Design - Interfering RNA molecules are now designed and produced with specificity for multiple binding sequences present in distinct genetic contexts in one or more pre-selected target RNA molecules and are used to modulate expression of the target sequences. Such a multitargeting interfering RNA approach provides a powerful tool for gene regulation. | 09-24-2009 |
20100286238 | SUPPRESSION OF VIRUSES INVOLVED IN RESPIRATORY INFECTION OR DISEASE - The present invention concerns methods and reagents useful in decreasing the level of or severity of respiratory infection or disease due to paramyxoviruses, such as RSV or HPIV, or coronavirus infection. Particularly, the invention relates to modulating gene expression using a multitargeting interfering RNA molecules that target multiple target sites on one or more pre-selected RNA molecules. | 11-11-2010 |
Laurent Pierre Rivory, Springwood AU
Patent application number | Description | Published |
---|---|---|
20090312399 | GUANOSINE-RICH OLIGONUCLEOTIDES AS AGENTS FOR INDUCING CELL DEATH IN EUKARYOTIC CELLS - The present invention relates to guanosine-rich oligonucleotides having the capacity to induce cell death, having characteristics of programmed cell death, in non-quiescent cells of higher eukaryotic organisms. The invention also relates to therapeutic methods involving the administration of these nucleic acid molecules to subjects suffering from, or being predisposed to, disorders involving abnormal cell proliferation and migration. The invention also concerns pharmaceutical compositions comprising the guanosine-rich nucleic acid molecules, in association with suitable carriers. | 12-17-2009 |